openPR Logo
Press release

Plasma Therapy Market Worth $882.5 Million by 2028 - Exclusive Report by Meticulous Research®

03-07-2024 02:02 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Meticulous Research®

In a recent market analysis report titled "Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes) - Global Forecast to 2028", published by Meticulous Research®, the plasma therapy market is anticipated to witness a robust growth trajectory, projecting a Compound Annual Growth Rate (CAGR) of 12.2% from 2021 onwards, aiming to reach a valuation of $882.5 million by 2028.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5218

The expansion of the plasma therapy market is primarily attributed to various factors, including the advantages associated with Platelet-rich Plasma (PRP) treatment, heightened awareness surrounding PRP therapies, the escalating prevalence of musculoskeletal, sports, and orthopedic injuries, as well as the surging demand for cosmetic procedures on a global scale. Furthermore, the increasing adoption of PRP treatments and advancements in healthcare infrastructure within emerging economies are anticipated to present significant growth avenues for plasma therapy providers.

Nevertheless, factors such as the availability of alternatives to PRP treatment and potential side-effects associated with PRP may somewhat impede the market's growth trajectory during the forecast period. Additionally, the stringent regulatory landscape governing PRP usage represents a notable challenge within this market domain.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5218

The global landscape of PRP therapy products witnessed substantial disruptions amidst the COVID-19 pandemic, affecting manufacturers, business proprietors, and suppliers across both developed and developing economies. Particularly, low- and middle-income countries encountered formidable obstacles due to inadequacies in healthcare infrastructure and regulatory constraints imposed by authorities on industries and suppliers. The pandemic induced a significant downturn in demand for PRP therapies in regenerative medicine and pain management, encompassing conditions such as tennis elbow, arthritis, torn ligaments, as well as cosmetic and plastic surgeries.

The Southeast Asian region bore a severe brunt of the pandemic's repercussions, as several countries in this locality heavily rely on revenue generated from exports and tourism. Furthermore, medical tourism witnessed substantial setbacks due to travel restrictions, exemplified by the drastic decline in revenues reported by the Malaysian Health Tourism Council (MHTC) in 2020 compared to the preceding year. The adverse impact on health tourism translated into diminished adoption of PRP treatments, thereby reducing the usage of PRP products.

Nevertheless, a surge in research focusing on PRP for COVID-related treatments has been observed. Notably, a study published in a scientific journal in July 2021 conducted in Indonesia in collaboration with various universities and hospitals explored the efficacy of intravenous autologous activated platelet-rich plasma therapy on profibrotic cytokine in severe and critical COVID-19 patients. The findings highlighted the potential of PRP in mitigating pulmonary fibrosis post-recovery from severe COVID-19 cases, thereby facilitating lung function improvement. This research resurgence on PRP contributed to market recovery and growth.

Quick Buy - Plasma Therapy Market Research Report: https://www.meticulousresearch.com/Checkout/88849114

The plasma therapy market is categorized based on various parameters including type (pure platelet-rich plasma, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte & platelet-rich fibrin), application (orthopedics and traumatology, dermatology and cosmetology, rheumatology, stomatology and odontology, ophthalmology, among others), end user (hospitals & clinics, research institutes), and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa). The report also assesses industry competitors and their market share at both global and regional levels.

By type, the pure PRP segment is anticipated to dominate the plasma therapy market owing to its distinct advantages over conventional PRP treatments, facilitated by a meticulous two-step concentration process eliminating red blood cells and neutrophils.

Based on application, the orthopedics & traumatology segment is projected to hold the largest market share in 2021, driven by an increasing incidence of musculoskeletal disorders and the endorsement of PRP therapy as an adjunct treatment for various conditions including fractures and chronic pain.

Regarding end user, hospitals & clinics are anticipated to command a larger market share in 2021, attributed to the widespread utilization of platelet-rich plasma therapy across a spectrum of applications including pain management, regenerative medicine, joint & bone surgeries, cosmetic enhancements, hair growth, and sports injuries.

Geographically, North America is poised to lead the global plasma therapy market in 2021, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The dominant market share of North America is ascribed to several factors including the presence of leading PRP providers, a substantial patient pool with orthopedic ailments, government support, and burgeoning adoption of PRP in cosmetic and dermatologic applications.

Key companies operating in the global plasma therapy market are Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.) among others.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/plasma-therapy-market-5218

Scope of the Report

Plasma Therapy Market, by Type

Pure PRP
Leukocyte-rich PRP
Pure Platelet Rich Fibrin
Leukocyte and Platelet Rich Fibrin

Plasma Therapy Market, by Application

Orthopedics and Traumatology
Dermatology and Cosmetology
Rheumatology
Stomatology and Odontology
Ophthalmology
Others
(Note: Other applications include sexual health, infertility support, migraine, and neurological issues)

Plasma Therapy Market, by End User

Hospitals & Clinics
Research Institutes

Plasma Therapy Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Brazil
Mexico
Argentina
Rest of LATAM (RoLATAM)
Middle East & Africa

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since its inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plasma Therapy Market Worth $882.5 Million by 2028 - Exclusive Report by Meticulous Research® here

News-ID: 3417748 • Views:

More Releases from Meticulous Research®

Direct Air Capture Market: Transforming Carbon Removal for a Net-Zero Future
Direct Air Capture Market: Transforming Carbon Removal for a Net-Zero Future
Introduction The global Direct Air Capture (DAC) market has entered a period of rapid transformation as nations, industries, and corporations intensify their efforts to achieve net-zero emissions. Valued at $136.5 million in 2024, the market is projected to grow significantly, reaching approximately $6.93 billion by 2035. This expansion, driven by a remarkable compound annual growth rate (CAGR) of 43.3% between 2025 and 2035, highlights the growing importance of DAC technologies in
European Direct-to-Consumer Genetic Testing Market Outlook 2025-2035
European Direct-to-Consumer Genetic Testing Market Outlook 2025-2035
Introduction The European direct-to-consumer (DTC) genetic testing market is expanding at a remarkable pace, reflecting rising consumer interest in personalized healthcare and genetic insights. Valued at $464 million in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 23.3%, reaching nearly $3.78 billion by 2035. This growth underscores how advances in genomic sequencing, combined with increasing health awareness, are reshaping the healthcare and wellness landscape
Peer-to-Peer Energy Trading Platforms Market Outlook 2025-2035
Peer-to-Peer Energy Trading Platforms Market Outlook 2025-2035
Introduction The global peer-to-peer (P2P) energy trading platforms market is undergoing rapid transformation as new technologies reshape how energy is generated, distributed, and traded. Valued at $138 million in 2024, the market is projected to grow significantly, reaching nearly $2.34 billion by 2035. This growth, at a compound annual growth rate (CAGR) of 29.7% from 2025 to 2035, highlights the increasing adoption of decentralized energy solutions and digital platforms that empower
Dermoscopy and Skin Visualization Devices Market Outlook to 2035
Dermoscopy and Skin Visualization Devices Market Outlook to 2035
Introduction The global dermoscopy and skin visualization devices market is entering a phase of rapid transformation, driven by the increasing need for early detection of skin conditions and the rising incidence of skin cancer worldwide. Valued at $1.33 billion in 2024, the market is expected to reach nearly $3.3 billion by 2035, expanding from an estimated $1.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.7% during the

All 5 Releases


More Releases for PRP

Therapeutic PRP Tubes Market to Witness Growth at a 6.6% CAGR by 2031 | Regen La …
QYResearch A newly published report titled "Global Therapeutic PRP Tubes Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Therapeutic PRP Tubes market. For instance, the market dynamics section digs deep into the
Global PRP Centrifuges Market Research Report 2023-2029
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global PRP Centrifuges Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a comprehensive analysis of the global PRP Centrifuges market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides advanced statistics
Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth. The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023" The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.